Nasal polyp. Nasal Polyps. Chronic sinusitis. Sinusitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient with chronic rhinosinusitis with bilateral nasal polyps; with or without allergy; with or without asthma; from any gender; older than 18 years old.
Exclusion criteria
Exclusion criteria: Patients younger than 18 years; women of childbearing or non-sterilized age; current or previous use of isotretinoin; history of nasal surgery for less than 5 years; non-controlled diabetic patients or poorly controlled hepatopathies and nephropathies; patients with cystic fibrosis or mucociliary diseases; presence of larger nasal tumors or malformations; cocaine or other inhaled drug user; patients with primary or secondary immunodeficiencies, coagulopathies, blood dysplasias, systemic or granulomatous vasculitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of nasal polyps volume, evaluated by nasofibroscopy, CT scan, and quality of life questionnaire, depicted as a reduction of at least 50% of polyps volume to nasofibroscopy and a reduction of 10% of the scores hailed from CT scan and quality of life questionnaire. Data collected 3 months before the intervention and 3 months after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decreased Th2 inflammatory cytokines present in the nasal polyp, measured by multiplex assays, present in homogenates of biopsy fragments, performed 3 months before the intervention and hailed months after the intervention. | — |
Countries
Brazil
Contacts
Departamento de Oftalmologia e Otorrinolaringologia, ambulatório de Rinologia